Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Baricitinib shows promise in treating severe hair loss.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

PRP may improve early ACL healing, but long-term effects are unclear.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Diphencyprone helped most patients with alopecia areata regrow some hair.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Proretinal nanoparticles improve skin absorption and reduce irritation of topical retinoids.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

JAK inhibitors may help improve symptoms in adults with APECED.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.